南方医科大学学报 ›› 2025, Vol. 45 ›› Issue (10): 2231-2239.doi: 10.12122/j.issn.1673-4254.2025.10.19
• • 上一篇
徐买元(
), 李妮, 李嘉懿, 张涛, 马俐文, 林涛, 余浩楠, 吴宁, 吴遵秋(
), 黄丽(
)
收稿日期:2025-04-05
出版日期:2025-10-20
发布日期:2025-10-24
通讯作者:
吴遵秋,黄丽
E-mail:2634892993@qq.com;457581851@qq.com;12155501@qq.com
作者简介:徐买元,在读本科生,E-mail: 2634892993@qq.com
基金资助:
Maiyuan XU(
), Ni LI, Jiayi LI, Tao ZHANG, Liwen MA, Tao LIN, Haonan YU, Ning WU, Zunqiu WU(
), Li HUANG(
)
Received:2025-04-05
Online:2025-10-20
Published:2025-10-24
Contact:
Zunqiu WU, Li HUANG
E-mail:2634892993@qq.com;457581851@qq.com;12155501@qq.com
Supported by:摘要:
目的 以转化生长因子β激活激酶1(TAK1)为靶标探讨葛根素(Pur)对胶原诱导型关节炎(CIA)大鼠滑膜炎症的作用机制。 方法 将60只健康SD大鼠随机均分为空白组(Nor)、模型组(Mod)、雷公藤多苷片阳性对照组(GTW,10 mg/kg)和葛根素低、中、高剂量组(Pur 10、30、100 mg/kg),10只/组。经皮下注射牛型Ⅱ胶原建立CIA大鼠模型,并通过每日经口灌胃的方式给予治疗,持续3周。采用关节炎指数(AI)评分法,分别于造模前1周,灌胃前1周及灌胃后第1、2、3周观察大鼠后足关节病变情况。计算大鼠肝脏指数,采用HE染色法观察大鼠关节滑膜病理变化,Real-time PCR法检测滑膜组织TAK1、TLR4、NF-κB p65 mRNA的表达水平,Western boltting检测滑膜组织TAK1、p-TAK1、TLR4、NF-κB p65蛋白表达水平。 结果 相较于Mod组,GTW组和Pur高剂量组大鼠肝脏指数下降(P<0.05)。GTW组和Pur低、中、高剂量组足跖肿胀度及关节炎指数评分均小于Mod组(P<0.05)。光镜下观察大鼠关节滑膜病理组织切片,Mod组可见滑膜细胞增生,滑膜水肿,滑膜结缔组织排列疏松、不规则,伴有少量以淋巴细胞、巨噬细胞为主的炎性细胞浸润;而GTW组和Pur低、中、高剂量组中,滑膜炎症均有不同程度的降低,且随Pur剂量增高,治疗效果呈逐渐增强的趋势。与Mod组比较,GTW组和Pur低、中、高剂量组大鼠膝关节滑膜组织中TAK1、TLR4、NF-κB p65 mRNA和蛋白表达量均有不同程度的降低(P<0.05)。 结论 葛根素可抑制CIA大鼠关节炎症反应,其机制可能为下调TAK1的表达,从而抑制TLR4/NF-κB信号转导途径。
徐买元, 李妮, 李嘉懿, 张涛, 马俐文, 林涛, 余浩楠, 吴宁, 吴遵秋, 黄丽. 葛根素通过调控TAK1介导的TLR4/NF-κB信号通路减轻大鼠类风湿关节炎症状[J]. 南方医科大学学报, 2025, 45(10): 2231-2239.
Maiyuan XU, Ni LI, Jiayi LI, Tao ZHANG, Liwen MA, Tao LIN, Haonan YU, Ning WU, Zunqiu WU, Li HUANG. Puerarin alleviates rheumatoid arthritis in rats by modulating TAK1-mediated TLR4/NF-κB signaling pathway[J]. Journal of Southern Medical University, 2025, 45(10): 2231-2239.
| Primer | Sequences |
|---|---|
GAPDH Forward: Reverse: | |
| 5'-GAAGCTGGTCATCAACGGGA-3' | |
| 5'-GGCGGAGATGATGACCCTTT-3' | |
TLR4 Forward: Reverse: | |
| 5'-CCGCTCTGGCATCATCTTCATTG-3' | |
| 5'-GCTTTTCCATCCAACAGGGCTTT-3' | |
TAK1 Forward: Reverse: | |
| 5'-ATCAACAAGCACCACCGTAA-3' | |
| 5'AATGTGGGAGTGGCTATCAGA-3' | |
NFκB-p65 Forward: Reverse: | |
| 5'-GCTTGCTTTAGCCCTTTGGT-3' | |
| 5'-AAGAGGGAAGAAGCCACCAG-3' |
表1 各基因的引物序列
Tab.1 Primer sequences used for Real-time PCR
| Primer | Sequences |
|---|---|
GAPDH Forward: Reverse: | |
| 5'-GAAGCTGGTCATCAACGGGA-3' | |
| 5'-GGCGGAGATGATGACCCTTT-3' | |
TLR4 Forward: Reverse: | |
| 5'-CCGCTCTGGCATCATCTTCATTG-3' | |
| 5'-GCTTTTCCATCCAACAGGGCTTT-3' | |
TAK1 Forward: Reverse: | |
| 5'-ATCAACAAGCACCACCGTAA-3' | |
| 5'AATGTGGGAGTGGCTATCAGA-3' | |
NFκB-p65 Forward: Reverse: | |
| 5'-GCTTGCTTTAGCCCTTTGGT-3' | |
| 5'-AAGAGGGAAGAAGCCACCAG-3' |
| Group | 1week before CIA modeling | 1week before gavage | 1 weeks of gavage | 2 weeks of gavage | 3 weeks of gavage |
|---|---|---|---|---|---|
| Normal | 1.435±0.332 | 1.418±0.215 | 1.442±0.235 | 1.456±0.324 | 1.436±0.243 |
| Model | 1.465±0.351 | 1.892±0.416*** | 1.852±0.632*** | 1.853±0.347*** | 1.865±0.359** |
| GTW | 1.441±0.236 | 1.798±0.342 | 1.633±0.285### | 1.536±0.245### | 1.425±0.257### |
| Pur 10 mg/kg | 1.425±0.317 | 1.865±0.416 | 1.831±0.375### | 1.768±0.447### | 1.703±0.654## |
| Pur 30 mg/kg | 1.437±0.341 | 1.843±0.324 | 1.736±0.458# | 1.563±0.152###▲ | 1.478±0.139##▲▲ |
| Pur 100 mg/kg | 1.427±0.387 | 1.824±0.332 | 1.715±0.519▲▲ | 1.6145±0.614##▲▲▲ | 1.444±0.335#▲▲▲ |
表2 葛根素对CIA大鼠双后肢足肿胀度的影响
Tab.2 Effect of puerarin on swelling of bilateral hind limb joints in rats with collagen-induced arthritis (Mean±SD, n=10)
| Group | 1week before CIA modeling | 1week before gavage | 1 weeks of gavage | 2 weeks of gavage | 3 weeks of gavage |
|---|---|---|---|---|---|
| Normal | 1.435±0.332 | 1.418±0.215 | 1.442±0.235 | 1.456±0.324 | 1.436±0.243 |
| Model | 1.465±0.351 | 1.892±0.416*** | 1.852±0.632*** | 1.853±0.347*** | 1.865±0.359** |
| GTW | 1.441±0.236 | 1.798±0.342 | 1.633±0.285### | 1.536±0.245### | 1.425±0.257### |
| Pur 10 mg/kg | 1.425±0.317 | 1.865±0.416 | 1.831±0.375### | 1.768±0.447### | 1.703±0.654## |
| Pur 30 mg/kg | 1.437±0.341 | 1.843±0.324 | 1.736±0.458# | 1.563±0.152###▲ | 1.478±0.139##▲▲ |
| Pur 100 mg/kg | 1.427±0.387 | 1.824±0.332 | 1.715±0.519▲▲ | 1.6145±0.614##▲▲▲ | 1.444±0.335#▲▲▲ |
图1 各组大鼠足肿胀度
Fig.1 Hind limb joint swelling of the rats in each group. A-F: Normal control group, CIA Model group, GTW group, Puerarin (Pur) 10 mg/kg group, Pur 30 mg/kg group, and Pur 100 mg/kg group, respectively. Joint swelling was measured using the same measurement standard and instrument calibration.
| Group | 1week before CIA modeling | 1week before gavage | 1 weeks of gavage | 2 weeks of gavage | 3 weeks of gavage |
|---|---|---|---|---|---|
| Normal | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 |
| Model | 6.52±1.22*** | 6.45±1.25*** | 6.44±1.34*** | 6.32±1.68*** | 6.37±1.39*** |
| GTW | 6.25±1.21 | 6.56±1.36 | 4.55±1.12# | 2.54±0.78## | 0.89±0.21### |
| Pur 10 mg/kg | 6.55±1.32 | 6.43±1.41 | 5.82±1.27 | 5.04±1.17# | 4.36±0.42## |
| Pur 30 mg/kg | 6.46±1.18 | 6.15±1.23 | 4.78±1.31 | 4.24±1.42 | 2.56±0.89 |
| Pur 100 mg/kg | 6.59±1.76 | 6.38±1.29 | 4.52±1.23 | 2.24±1.02 | 0.74±0.15 |
表3 葛根素对CIA大鼠关节AI评分的影响
Tab.3 Effect of puerarin on arthritis index score in rats with collagen-induced arthritis (Mean±SD, n=10)
| Group | 1week before CIA modeling | 1week before gavage | 1 weeks of gavage | 2 weeks of gavage | 3 weeks of gavage |
|---|---|---|---|---|---|
| Normal | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 |
| Model | 6.52±1.22*** | 6.45±1.25*** | 6.44±1.34*** | 6.32±1.68*** | 6.37±1.39*** |
| GTW | 6.25±1.21 | 6.56±1.36 | 4.55±1.12# | 2.54±0.78## | 0.89±0.21### |
| Pur 10 mg/kg | 6.55±1.32 | 6.43±1.41 | 5.82±1.27 | 5.04±1.17# | 4.36±0.42## |
| Pur 30 mg/kg | 6.46±1.18 | 6.15±1.23 | 4.78±1.31 | 4.24±1.42 | 2.56±0.89 |
| Pur 100 mg/kg | 6.59±1.76 | 6.38±1.29 | 4.52±1.23 | 2.24±1.02 | 0.74±0.15 |
图2 葛根素对CIA大鼠肝脏质量分数的影响
Fig.2 Effect of puerarin on mass fraction of the liver of the rats with collagen-induced arthritis (Mean±SD, n=10). *P<0.05 vs the Nor group; #P<0.05, ##P<0.01 vs the Mod group.
图3 各组大鼠滑膜组织病理改变
Fig.3 Pathological changes in the synovium of the rats. (HE staining, original magnification: ×100). A-F: Normal control group, CIA model group, GTW group, Puerarin(Pur) 10 mg/kg group, Pur 30 mg/kg group, and Pur 100 mg/kg group, respectively. Black arrows indicate synovial cell hyperplasia, yellow arrows denote shedding of synovial cells, green arrows indicate connective tissue hyperplasia, and purple arrows highlight widening of collagen fiber interstices.
图5 葛根素对CIA大鼠中TAK1、p-TAK1、TLR4、NF-κB p65 蛋白表达水平的影响
Fig.5 Effect of puerarin on expression levels of TAK1, p-TAK1, NF-κB p65 and TLR4 proteins in the synovium of the rats with collagen-induced arthritis (n=10). A: Expression levels of TAK1 and p-TAK1 proteins in the synovium of the rats. B: Expression level of TLR4 protein in the synovium of the rats. C: Expression level of NF-κB p65 protein in the synovium of the rats. D: Western blotting for detecting expression levels of TAK1, p-TAK1, NF-κB p65 and TLR4 in each group. **P<0.01,***P<0.001 vs the Nor group; #P<0.05, ##P<0.01, ###P<0.001 vs the Mod group.
| [1] | 高 志, 吴 傲, 胡仲翔, 等. 类风湿性关节炎中氧化应激与免疫浸润的生物信息学分析[J]. 南方医科大学学报, 2025, 45(04): 862-70. |
| [2] | 姜海昆, 芦鸿雁, 段吉隆, 等. 类风湿关节炎病人健康素养的研究进展[J]. 护理研究, 2025, 39(7): 1221-5. |
| [3] | 王洋洋, 徐 媛, 苑功名, 等. 类风湿关节炎骨破坏及其针灸治疗的骨免疫学机制研究现状[J]. 山东中医杂志, 2022, 41(3): 343-7. |
| [4] | 祝 静, 晏 波, 蒋 瑶, 等. 女性类风湿关节炎患者miR-146a、miR-23b的表达及雌激素对其的影响[J]. 川北医学院学报, 2020, 35(4): 637-41. |
| [5] | Wijdeven RH, Janssen H, Nahidiazar L, et al. Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway[J]. Nat Commun, 2016, 7: 11808. doi:10.1038/ncomms11808 |
| [6] | Jiang LQ, Zhang RD, Musonye HA, et al. Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants[J]. RMD Open, 2024, 10(1): e003338. doi:10.1136/rmdopen-2023-003338 |
| [7] | Scarneo SA, Eibschutz LS, Bendele PJ, et al. Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice[J]. Arthritis Res Ther, 2019, 21(1): 292. doi:10.1186/s13075-019-2073-x |
| [8] | Jo S, Samarpita S, Lee JS, et al. 8-Shogaol inhibits rheumatoid arthritis through targeting TAK1[J]. Pharmacol Res, 2022, 178: 106176. doi:10.1016/j.phrs.2022.106176 |
| [9] | Li X, Li M. Erratum: Estrogen downregulates TAK1 expression in human fibroblast-like synoviocytes and in a rheumatoid arthritis model[J]. Exp Ther Med, 2022, 23(3): 225. doi:10.3892/etm.2022.11149 |
| [10] | Xu YR, Lei CQ. TAK1-TABs complex: a central signalosome in inflammatory responses[J]. Front Immunol, 2020, 11: 608976. doi:10.3389/fimmu.2020.608976 |
| [11] | Bao Y, Sun YW, Ji J, et al. Genkwanin ameliorates adjuvant-induced arthritis in rats through inhibiting JAK/STAT and NF-κB signaling pathways[J]. Phytomedicine, 2019, 63: 153036. doi:10.1016/j.phymed.2019.153036 |
| [12] | Li L, Pan Z, Ning D, et al. Rosmanol and carnosol synergistically alleviate rheumatoid arthritis through inhibiting TLR4/NF‑κB/MAPK pathway[J]. Molecules, 2021, 27(1): 78. doi:10.3390/molecules27010078 |
| [13] | 胡丹东, 崔玉娟, 张 继 .亚油酸通过调节TLR4/NF-κB信号通路减轻大鼠类风湿关节炎[J]. 中国药理学通报, 2021, 37(9): 1213-8. |
| [14] | Wi SM, Moon G, Kim J, et al. TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-κB[J]. J Biol Chem, 2014, 289(51): 35205-14. doi:10.1074/jbc.m114.597187 |
| [15] | 李朝霞, 高 鲁, 张晓峰, 等. 铁死亡在类风湿性关节炎中的研究进展[J]. 中国骨质疏松杂志, 2024, 30(6): 889-94. |
| [16] | Cush JJ. Rheumatoid arthritis: early diagnosis and treatment[J]. Med Clin North Am, 2021, 105(2): 355-65. doi:10.1016/j.mcna.2020.10.006 |
| [17] | Tian X, Wang Q, Li M, et al. 2018 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis[J]. Rheumatol Immunol Res, 2021, 2(1): 1-14. doi:10.2478/rir-2021-0002 |
| [18] | 禄成龙, 宫玉锁, 刘建平, 等. 中医药介导OPG/RANK/RANKL信号通路防治类风湿关节炎的研究进展[J]. 数理医药学杂志, 2023, 36(9): 697-707. |
| [19] | 宋泽冲, 照日格图. 中医药治疗类风湿关节炎研究进展[J]. 新疆中医药, 2021, 39(1): 113-6. |
| [20] | 孟晓伟, 郭风梅, 王倩倩, 等. 葛根素的药理作用研究进展[J/OL]. 中国中药杂志, 2025, 50(11): 2954-68. |
| [21] | Sun J, Liu Y, Zhang J, et al. Puerarin attenuates insulin resistance by inhibiting endoplasmic reticulum stress and suppresses inflammation by modulating the JNK and IKKβ/NF-κB pathways in epididymal white adipose tissue of mice on a high-fat diet[J]. Mol Nutr Food Res, 2024, 68(16): e2400003. doi:10.1002/mnfr.202400003 |
| [22] | 杨占华, 郝连升, 张建新. 葛根素对骨质疏松大鼠氧化应激反应、骨代谢和骨密度的影响[J]. 中国骨质疏松杂志, 2021, 27(3): 413-7. |
| [23] | Chakraborty D, Gupta K, Biswas S. A mechanistic insight of phytoestrogens used for Rheumatoid arthritis: an evidence-based review[J]. Biomed Pharmacother, 2021, 133: 111039. doi:10.1016/j.biopha.2020.111039 |
| [24] | 祁 琳, 李新敏, 张玲玲, 等. 葛根素对人成骨样MG-63细胞OPG、RANKL表达的调节作用[J]. 武警后勤学院学报: 医学版, 2020, 29(2): 1-6. |
| [25] | 高 月, 唐 芳, 马武开, 等. 基于网络药理学和动物实验探讨葛根素治疗类风湿关节炎的作用机制[J]. 安徽医科大学学报, 2025, 60(1): 22-31. |
| [26] | Zhao Y, Wu J, Liu X, et al. Decoding nature: multi-target anti-inflammatory mechanisms of natural products in the TLR4/NF-κB pathway[J]. Front Pharmacol, 2024, 15: 1467193. doi:10.3389/fphar.2024.1467193 |
| [27] | Wang C, Wang W, Jin X, et al. Puerarin attenuates inflammation and oxidation in mice with collagen antibody-induced arthritis via TLR4/NF-κB signaling[J]. Mol Med Rep, 2016, 14(2): 1365-70. doi:10.3892/mmr.2016.5357 |
| [28] | Zhang Y, Yan M, Yu QF, et al. Puerarin prevents LPS-induced osteoclast formation and bone loss via inhibition of Akt activation[J]. Biol Pharm Bull, 2016, 39(12): 2028-35. doi:10.1248/bpb.b16-00522 |
| [29] | 梁俊晖, 张常娥. 葛根素对骨性关节炎模型兔的作用机制研究[J]. 检验医学与临床, 2016, 13(20): 2884-6. |
| [30] | 宋锡国, 苑文杰, 肖淑卿, 等. 葛根素治疗类风湿性关节炎的应用及临床有效性探究[J]. 东方药膳, 2021, (015): 206. |
| [31] | 高 远, 李 冀, 韩东卫, 等. 基于TLR4/NF-κB炎性轴的白芥子经皮给药对类风湿性关节炎大鼠调控机制研究[J]. 中医药学报, 2023, 51(8): 17-22. |
| [32] | Hu ZJ, Chen D, Yan PH, et al. Puerarin suppresses macrophage M1 polarization to alleviate renal inflammatory injury through antagonizing TLR4/MyD88-mediated NF-κB p65 and JNK/FoxO1 activation[J]. Phytomedicine, 2024, 132: 155813. doi:10.1016/j.phymed.2024.155813 |
| [33] | Xie W, Li H, Yu T, et al. Design and synthesis of hederagenin derivatives for the treatment of sepsis by targeting TAK1 and regulating the TAK1-NF-κB/MAPK signaling[J]. J Med Chem, 2025, 68(3): 2694-719. |
| [34] | 杨丽萍, 张国用, 周人杰, 等. 葛根素通过TLR4/NF-κB信号通路对心力衰竭大鼠心肌炎症反应的影响[J]. 中国免疫学杂志, 2024, 40(5): 1042-7. |
| [35] | Wang W, Pang C, Zhang J, et al. Takinib inhibits microglial M1 polarization and oxidative damage after subarachnoid hemorrhage by targeting TAK1-dependent NLRP3 inflammasome signaling pathway[J]. Front Immunol, 2023, 14: 1266315. doi:10.3389/fimmu.2023.1266315 |
| [36] | 王丹姝, 燕柳艳, 孙姝婵, 等. 葛根素通过TLR4/Myd88/NF-κB抑制NLRP3炎症小体抗大鼠心肌缺血再灌注损伤[J]. 药学学报, 2021, 56(5): 1343-51. |
| [37] | Ke LQ, He QF, Qu J, et al. Bone-protective effects of neutralizing angiopoietin-like protein 4 monoclonal antibody in rheumatoid arthritis[J]. Mol Ther, 2024, 32(12): 4497-513. doi:10.1016/j.ymthe.2024.09.031 |
| [38] | 杨豫正, 姚晓玲, 罗 丰, 等. 雷公藤治疗类风湿关节炎作用机制的生物信息学分析及实验验证[J]. 中医杂志, 2025, 66(7): 724-33. |
| [39] | 许林帅, 常 岑, 时一鸣, 等. 雷公藤及其有效成分治疗类风湿性关节炎的研究进展[J]. 上海中医药杂志, 2023, 57(5): 91-5. |
| [40] | 张 依, 王晓月, 丁子禾, 等. 中药配伍雷公藤制剂治疗类风湿关节炎的安全性系统评价及其增效减毒网络调控机制[J]. 中国实验方剂学杂志, 2023, 29(5): 1-8. |
| [41] | 田赵威, 刘晨风, 王 琛. 葛根素在重大慢性疾病临床应用中的探索研究[J]. 中国中医基础医学杂志, 2024, 30(3): 522-9. |
| [42] | 赵欣磊, 王建国, 刘有才, 等. 基于JAK2/STAT3信号通路探讨葛根素治疗绝经后骨质疏松症大鼠的作用机制[J]. 包头医学院学报, 2025, 41(1): 25-31. |
| [43] | Mihaly SR, Ninomiya-Tsuji J, Morioka S. TAK1 control of cell death[J]. Cell Death Differ, 2014, 21(11): 1667-76. doi:10.1038/cdd.2014.123 |
| [44] | Scarneo S, Zhang X, Wang Y, et al. Transforming growth factor-β-activated kinase 1 (TAK1) mediates chronic pain and cytokine production in mouse models of inflammatory, neuropathic, and primary pain[J]. J Pain, 2023, 24(9): 1633-44. doi:10.1016/j.jpain.2023.04.011 |
| [45] | Yang J, Li Y, Wang L, et al. LncRNA H19 aggravates TNF-α-induced inflammatory injury via TAK1 pathway in MH7A cells[J]. Biofactors, 2020, 46(5): 813-20. doi:10.1002/biof.1659 |
| [46] | 莫选荣, 谢江文, 吕国菊, 等. TAK1基因沉默对TNF-a诱导的滑膜细胞IL-6、IL-8表达的影响[J]. 中国应用生理学杂志, 2017, 33(5): 471-5. |
| [47] | Freeze R, Yang KW, Haystead T, et al. Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis[J]. Pharmacol Res Perspect, 2023, 11(4): e01124. doi:10.1002/prp2.1124 |
| [48] | Xia ZB, Meng FR, Fang YX, et al. Inhibition of NF-κB signaling pathway induces apoptosis and suppresses proliferation and angiogenesis of human fibroblast-like synovial cells in rheumatoid arthritis[J]. Medicine: Baltimore, 2018, 97(23): e10920. doi:10.1097/md.0000000000010920 |
| [49] | Maracle CX, Kucharzewska P, Helder B, et al. Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis[J]. Rheumatology: Oxford, 2017, 56(2): 294-302. doi:10.1093/rheumatology/kew393 |
| [50] | Noort AR, Tak PP, Tas SW. Non-canonical NF‑κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde[J]? Arthritis Res Ther, 2015, 17: 15. doi:10.1186/s13075-015-0527-3 |
| [51] | Wang Q, Zhou X, Zhao Y, et al. Polyphyllin I ameliorates collagen-induced arthritis by suppressing the inflammation response in macrophages through the NF-κB pathway[J]. Front Immunol, 2018, 9: 2091. doi:10.3389/fimmu.2018.02091 |
| [52] | 单佳铃, 程虹毓, 文 乐, 等. TLR/MyD 88/NF-κB信号通路参与不同疾病作用机制研究进展[J]. 中国药理学通报, 2019, 35(4): 451-5. |
| [1] | 李玮怡, 江露, 张宗星, 陈丹, 包卓玛, 黄丽, 袁林. 强骨康疏方通过抑制HIF-1α/BNIP3自噬信号通路减少类风湿性关节炎大鼠的破骨细胞分化[J]. 南方医科大学学报, 2025, 45(7): 1389-1396. |
| [2] | 高志, 吴傲, 胡仲翔, 孙培养. 类风湿性关节炎中氧化应激与免疫浸润的生物信息学分析[J]. 南方医科大学学报, 2025, 45(4): 862-870. |
| [3] | 曹周芳, 汪元, 王梦娜, 孙玥, 刘菲菲. LINC00837/miR-671-5p/SERPINE2功能轴促进类风湿关节炎成纤维细胞样滑膜细胞的恶性病理学过程[J]. 南方医科大学学报, 2025, 45(2): 371-378. |
| [4] | 展俊平, 黄硕, 孟庆良, 范围, 谷慧敏, 崔家康, 王慧莲. 缺氧微环境下补阳还五汤通过抑制BNIP3-PI3K/Akt通路抑制类风湿关节炎滑膜成纤维细胞的线粒体自噬[J]. 南方医科大学学报, 2025, 45(1): 35-42. |
| [5] | 杨锐, 舒翊秦, 文晖杰, 蔡熹, 王震, 张棽, 向阳, 吴昊. 枫杨总黄酮通过抑制中性粒细胞胞外陷阱网的释放减轻大鼠类风湿关节炎[J]. 南方医科大学学报, 2024, 44(9): 1645-1652. |
| [6] | 陈莉莉, 吴天宇, 张铭, 丁子夏, 张妍, 杨依清, 郑佳倩, 张小楠. 类风湿关节炎的潜在生物标志物及其免疫调控机制:基于GEO数据库[J]. 南方医科大学学报, 2024, 44(6): 1098-1108. |
| [7] | 王帆帆, 刘 健, 方妍妍, 文建庭, 贺明玉, 韩 琦, 李 旭. 中医药治疗可降低类风湿关节炎合并血小板升高患者再入院的风险:一项匹配队列研究[J]. 南方医科大学学报, 2023, 43(9): 1548-1557. |
| [8] | 郭晶晶, 张文龙, 梁 飘, 张龙军, 彭凌音, 闵钰琦, 潘小珍, 杨志英, 邓华菲. 葛根素减轻LPS诱导的小鼠急性肾损伤:基于调节SIRT1/NF-κB信号通路[J]. 南方医科大学学报, 2023, 43(7): 1248-1253. |
| [9] | 张雪芳, 陈延华, 李宗恒, 尚 靖, 袁泽婷, 邓皖利, 骆 莺, 韩 娜, 殷佩浩, 殷 军. 六神丸治疗小鼠结肠炎相关性结直肠癌的作用机制:基于网络药理学和体内验证方法[J]. 南方医科大学学报, 2023, 43(7): 1051-1062. |
| [10] | 宗世烨, 周 静, 蔡伟伟, 余 芸, 王 颖, 宋宜宁, 程静文, 李宇会, 高 艺, 吴百海, 咸 郝, 魏 芳. 小檗碱抑制类风湿关节炎患者的成纤维样滑膜细胞的自噬并促进其凋亡:基于下调ROS/mTOR信号通路[J]. 南方医科大学学报, 2023, 43(4): 552-559. |
| [11] | 刘天阳, 周学平, 黄传兵, 周玲玲, 谌 曦, 万 磊, 纵瑞凯, 范海霞, 孙 玥, 俞志超, 汤忠富, 徐耿瑞, 周子译. 清络通痹方调控类风湿关节炎“免疫-骨侵蚀”的机制[J]. 南方医科大学学报, 2023, 43(10): 1706-1714. |
| [12] | 唐 娟, 陈 娟, 林国新, 张 浩, 桂 明, 李楠楠, 谷依红, 罗林娟, 孙 剑. 中性粒细胞/淋巴细胞、血小板/淋巴细胞比值是评价托法替尼治疗后类风湿关节炎活动性的有效指标[J]. 南方医科大学学报, 2023, 43(10): 1651-1656. |
| [13] | 周思聪, 杨 威, 曾 丽, 曹春浩, 袁 速, 荣晓凤. 大黄素对胶原诱导性关节炎大鼠的骨保护作用:基于抑制铁死亡和降解基质金属蛋白酶[J]. 南方医科大学学报, 2023, 43(10): 1776-1781. |
| [14] | 王 静, 陈雪祎, 孙 丽, 陈雪梅, 李 慧, 熊彬睿, 王海华. 长链非编码RNA ZEB1-AS1通过HMGB1/TLR-4信号轴加剧大鼠脑缺血/再灌注损伤[J]. 南方医科大学学报, 2022, 42(8): 1134-1142. |
| [15] | 曹春浩, 曾 丽, 荣晓凤. 大黄素治疗类风湿关节炎的作用机制:基于网络药理学方法[J]. 南方医科大学学报, 2022, 42(6): 913-921. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||